- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Anupam Rasayan Q1FY27 consolidated revenue grew 36% YoY to Rs 667.5 Cr, with EBITDA up 35% to Rs 174.9 Cr. PAT rose 6% to Rs 51.2 Cr. Achieved ETFA commercialization milestone. Signed US$300 million LoI with BASQUEVOLT. Bliss GVS Pharma acquisition progressing.